Medicamen Biotech, a pharmaceutical company, is expanding into the domestic market through its subsidiary Medicamen Life Sciences.

Medicamen group chairman Rahul Bishnoi stated, "The company's vision is to become a most admired pharmaceutical organisation by offering research and data-backed, affordable and quality medicines for the Indian population. To begin with, the company has entered the cardio-vascular & Diabetes (CVD) business, which contributes annual revenue of more than Rs 50,000 crore to IPM with a CAGR of 11 per cent."

Kamal Pahwa, a pharma veteran with 32 years of experience in the CVD business and Pramod Sharma of Neelkanth Drugs, India's top distribution network, have joined forces with Medicamen to establish this extremely ambitious initiative, stated Bishnoi.